JPH10512594A - ヒトの黄斑変性を治療するための純粋なゼアキサンチンの3r−3’r立体異性体 - Google Patents

ヒトの黄斑変性を治療するための純粋なゼアキサンチンの3r−3’r立体異性体

Info

Publication number
JPH10512594A
JPH10512594A JP9517583A JP51758397A JPH10512594A JP H10512594 A JPH10512594 A JP H10512594A JP 9517583 A JP9517583 A JP 9517583A JP 51758397 A JP51758397 A JP 51758397A JP H10512594 A JPH10512594 A JP H10512594A
Authority
JP
Japan
Prior art keywords
zeaxanthin
cells
stereoisomer
composition
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9517583A
Other languages
English (en)
Japanese (ja)
Inventor
ガーネット,ケビン・エム
ギアハート,デニス・エル
ガラサントス,ルイス・エイチ
Original Assignee
アプライド・フード・バイオテクノロジー・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by アプライド・フード・バイオテクノロジー・インコーポレイテッド filed Critical アプライド・フード・バイオテクノロジー・インコーポレイテッド
Publication of JPH10512594A publication Critical patent/JPH10512594A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP9517583A 1995-10-31 1996-10-30 ヒトの黄斑変性を治療するための純粋なゼアキサンチンの3r−3’r立体異性体 Pending JPH10512594A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/551,166 1995-10-31
US08/551,153 1995-10-31
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
PCT/US1996/017563 WO1997016175A1 (en) 1995-10-31 1996-10-30 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans

Publications (1)

Publication Number Publication Date
JPH10512594A true JPH10512594A (ja) 1998-12-02

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9517583A Pending JPH10512594A (ja) 1995-10-31 1996-10-30 ヒトの黄斑変性を治療するための純粋なゼアキサンチンの3r−3’r立体異性体

Country Status (14)

Country Link
JP (1) JPH10512594A (pt)
KR (1) KR100570251B1 (pt)
CN (1) CN1104235C (pt)
AR (1) AR004245A1 (pt)
AU (1) AU710634B2 (pt)
BR (1) BR9611488A (pt)
CZ (1) CZ297575B6 (pt)
FI (1) FI980947A (pt)
HU (1) HU223208B1 (pt)
NO (1) NO981698L (pt)
PL (1) PL185465B1 (pt)
RU (1) RU2197958C2 (pt)
WO (1) WO1997016175A1 (pt)
ZA (1) ZA969139B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) 2005-01-21 2005-03-02 Promar As Compositions
AU2006213635B2 (en) * 2005-02-11 2010-06-17 Kalamazoo Holdings, Inc. A Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
DK0534955T3 (da) * 1989-08-30 1997-10-13 Applied Food Biotech Inc Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
HUP9802314A2 (hu) 1999-04-28
PL185465B1 (pl) 2003-05-30
KR100570251B1 (ko) 2006-06-21
AU710634B2 (en) 1999-09-23
CZ130998A3 (cs) 1998-07-15
FI980947A0 (fi) 1996-10-30
PL326558A1 (en) 1998-09-28
HUP9802314A3 (en) 1999-05-28
HU223208B1 (hu) 2004-03-29
MX9605248A (es) 1998-06-30
CN1104235C (zh) 2003-04-02
CN1201388A (zh) 1998-12-09
RU2197958C2 (ru) 2003-02-10
AU7050196A (en) 1997-05-08
ZA969139B (en) 1997-09-25
AR004245A1 (es) 1998-11-04
NO981698D0 (no) 1998-04-16
FI980947A (fi) 1998-04-29
KR19990067180A (ko) 1999-08-16
CZ297575B6 (cs) 2007-02-07
BR9611488A (pt) 1999-01-19
WO1997016175A1 (en) 1997-05-09
NO981698L (no) 1998-06-08

Similar Documents

Publication Publication Date Title
US5827652A (en) Zeaxanthin formulations for human ingestion
US5854015A (en) Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
US5747544A (en) Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
US6265450B1 (en) Anti-stress composition
AU2006266751B2 (en) Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions
US9849178B2 (en) Combination of carotenoids and epi-lutein
JPH0249091A (ja) アスタキサンチン含有組成物
JPH10155459A (ja) アスタキサンチン含有飲食物
JPH10276721A (ja) アスタキサンチン含有飲食物
JP2011063563A (ja) しわ改善組成物
US7691406B2 (en) Zeaxanthin formulations for human ingestion
EP0774251B1 (en) 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans
AU710634B2 (en) Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans
JP2001136959A (ja) 枯草菌菌体および/またはその産生物を含む培養物、これに由来する水溶性ビタミンk誘導体、これらを含む医薬、食品および飼料ならびにこれらの製造方法
WO1997016175A9 (en) Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans
WO2020059745A1 (ja) 脳腫瘍またはそれに起因する症状の抑制または治療のための組成物
WO2007034958A1 (ja) 穀類由来の成分を有効成分とする血管新生阻害の作用を有する組成物
MXPA96005248A (en) Pure 3r-3'r stereoisomer of zeaxantin to treat macular degeneration in human beings
WO2024075625A1 (ja) 視野欠損障害、光誘発眼組織障害およびその関連障害の予防剤、進行防止剤、改善剤、並びに食品
JP2010163362A (ja) 軸性近視抑制剤及び遠視抑制剤
JP2002212094A (ja) コレステロール生成抑制剤及びその製造方法

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070515

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070810

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070914

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070914

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071106